Article Information
vol. 10 no. 429
- Received for publication May 31, 2016
- Resubmitted February 23, 2017
- Accepted for publication September 26, 2017
- .
Author Information
- Joe L. Hsu1,2,
- Olga V. Manouvakhova2,
- Karl V. Clemons3,4,
- Mohammed Inayathullah5,
- Allen B. Tu2,
- Raymond A. Sobel6,7,
- Amy Tian2,
- Hasan Nazik3,4,8,
- Venkata R. Pothineni5,
- Shravani Pasupneti1,2,
- Xinguo Jiang2,
- Gundeep S. Dhillon1,
- Harmeet Bedi1,
- Jayakumar Rajadas1,5,
- Hubertus Haas9,
- Laure Aurelian10,
- David A. Stevens3,4 and
- Mark R. Nicolls1,2,*
- 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 2Veterans Affairs Palo Alto Health Care System, Medical Service, Palo Alto, CA 94304, USA.
- 3Infectious Diseases Research Laboratory, California Institute for Medical Research, San Jose, CA 95128, USA.
- 4Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 5Biomaterials and Advanced Drug Delivery Laboratory, Cardiovascular Pharmacology Division, Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94304, USA.
- 6Veterans Affairs Palo Alto Health Care System, Pathology and Laboratory Service, Palo Alto, CA 94304, USA.
- 7Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 8Department of Medical Microbiology, Istanbul University School of Medicine, Istanbul, Turkey.
- 9Division of Molecular Biology, Medical University Innsbruck, Innsbruck, Austria.
- 10Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- ↵*Corresponding author. Email: mnicolls{at}stanford.edu